Dare Bioscience, Inc (DARE) Stock Price

0.7135 ▼ -0.0265 (-3.58%)
Open: 0.7135 Vol: 0 Day's range: 0.7135 - 0.7135 Oct 16, 15:43 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
DARE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.72▼ 0.73▼ 0.73▼ 0.74▼ 0.78▼
MA10 0.73▼ 0.73▼ 0.73▼ 0.77▼ 0.78▼
MA20 0.73▼ 0.75▼ 0.76▼ 0.79▼ 1.30▼
MA50 0.79▼ 0.81▼ 0.81▼ 0.84▼ 1.69▼
MA100 0.81▼ 0.81▼ 0.79▼ 1.34▼ 2.21▼
MA200 0.79▼ 0.78▼ 0.78▼ 1.65▼ 4.65▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.002▲ 0.001▲ -0.001▼ -0.002▼ -0.040▼
RSI 29.497▼ 30.666▼ 31.029▼ 36.125▼ 34.423▼
STOCH 35.586     21.713     20.246     10.703▼ 8.901▼
WILL %R -100.000▼ -100.000▼ -100.000▼ -100.000▼ -98.379▼
CCI -150.101▼ -161.418▼ -127.364▼ -123.177▼ -59.403    
Latest Filters Detected On DARE
▼ MACD $DARE MACD(12,26,9) Crossed Below Signal Line Set Alert
▼ GAP $DARE Open Gap Down %3 Set Alert
▼ GAP $DARE Open Gap Down %2 Set Alert
▼ BREAK $DARE Price Breaks 10 Days Low Set Alert
CDL $DARE Doji Candlestick Pattern Detected Set Alert
Dare Bioscience, Inc News
Daré Bioscience Launches “CEO Corner” Video Series to Highlight the Company’s Pipeline of Women’s Health Innovations, Corporate Strategy and Opportunities
Tuesday, October 13, 2026 06:15 AM
New video series featuring Founder, President and CEO Sabrina Martucci Johnson will provide investors with insights into Daré Bioscience’s growing commercial portfolio, clinical pipeline and strategic ...
Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting
Thursday, October 08, 2026 02:15 AM
Annie Thurman, MD, FACOG, Medical Director of Daré Bioscience, will present “An Open-Label, Single-Dose, Randomized, Parallel-Cohort Study of the Safety and Relative Bioavailability of Topical ...
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
Monday, September 28, 2026 05:20 AM
New U.S. patent expands intellectual property foundation for DARE-HPV, a potential first-in-category treatment targeting persistent high-risk HPV infection DARE-HPV Phase 2 study underway with topline ...
DARE historical stock data
date open high low close volume
16/10/26 0.7135 0.7135 0.7135 0.7135 74,341
15/10/26 0.73 0.7462 0.7204 0.74 96,943
14/10/26 0.7426 0.7426 0.7203 0.729 60,882
13/10/26 0.786 0.786 0.73 0.7477 112,597
12/10/26 0.77 0.7901 0.7381 0.7501 80,377
09/10/26 0.79 0.7904 0.7601 0.7734 68,968
08/10/26 0.7862 0.80 0.755 0.7722 165,741
07/10/26 0.8143 0.8194 0.79 0.79 113,070
06/10/26 0.83 0.88 0.83 0.8331 88,343
05/10/26 0.833 0.8689 0.8308 0.8431 157,134
Quote Details
52wk Low:0.69
52wk High:3.78
Vol:0
Avg Vol(3m):8.4M
1Y Chng:-62.84%
1M Chng:-1.04%
Add to Watch List
More Information
Index US Composite
Market Cap. 14.17M